ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
The Kerala High Court ruled Monday that the government may intervene when patented medicines are prohibitively priced, directing the Centre to collect nationwide affordability data for abemaciclib and ribociclib, two breast cancer drugs from Eli Lilly and Novartis. The court said Section 100 of the Patents Act could be invoked, but left the decision and timeline to the government.
Tap to vote and see what everyone thinks.
Summary by ByteBrief